The gold price has soared this year allowing commodity investment trusts to come back into favour once again.
Exploring the world of investment trusts
My personal views on what’s happening in the wacky world of investment trusts…
The gold price has soared this year allowing commodity investment trusts to come back into favour once again.
A few weeks ago, I wrote about how I had offloaded Princess Private Equity and part of my holding in Murray International to buy a basket of biotech trusts.
QQQ is the ticker for the most popular Nasdaq 100 ETF in the US. With $135bn in assets, it’s about five times the size of Fundsmith Equity, the UK’s largest fund. And it’s beaten pretty much every single UK investment trust and open-ended fund over the last decade.
The various investment trusts and funds run by Baillie Gifford are dominating the performance charts this year. It’s no flash in the pan, though, as their long-term record is arguably even more impressive.
Our house is being battered by a thunderstorm as I write this. Owning a UK smaller company investment trust in 2020 has felt very similar. But storms pass.
After a year of procrastination, I’ve finally taken the plunge and bought into the biotech and healthcare sector.
Smithson’s shares are up more than 50% since it floated in October 2018 and its share count has risen 52%. It’s now approaching £2bn in market cap and it’s already become one of the 20 largest UK investment trusts.
One of the attractions of the investment trust sector is the way it regularly renews itself, backing its winners and cutting loose what doesn’t seem to work.
Last weekend saw the first Mello Virtual investing conference, concentrating mainly on UK small-caps and trusts/funds. I very much enjoyed the physical version last year and I’d say this one was equally good.
I decided to take up running on my 30th birthday after realising my 20s lifestyle, though not overly excessive, had given me a bit of a paunch.
Copyright © 2018-2024 www.itinvestor.co.uk
Disclaimer: This site is for informational purposes only. We make no assertions as to the accuracy, completeness, suitability or validity of anything on this site.
We will not be liable for any errors or omissions or any damages arising from its display or use. Here's our privacy and cookie policy.